Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TARA

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
11/19/20214:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
11/08/20212:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
11/04/20214:46PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
11/04/20218:00AMGlobeNewswire Inc.Protara Therapeutics Announces Third Quarter 2021 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
10/25/20214:45PMGlobeNewswire Inc.Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
10/18/20215:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
10/12/20217:56AMDow Jones NewsProtara Therapeutics: FDA Clears IND Application for TARA-002 in Bladder CancerNASDAQ:TARAProtara Therapeutics Inc
10/12/20217:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
10/12/20217:00AMGlobeNewswire Inc.Protara Therapeutics Announces FDA Clearance of Investigational New Drug Application for TARA-002 for the Treatment of Non-Muscle Invasive Bladder CancerNASDAQ:TARAProtara Therapeutics Inc
09/17/20214:05PMGlobeNewswire Inc.Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech SummitNASDAQ:TARAProtara Therapeutics Inc
09/13/20217:00AMGlobeNewswire Inc.Protara Therapeutics Announces Results from a Retrospective Study Evaluating the Prevalence of Cholestasis in Patients Dependent on Parenteral NutritionNASDAQ:TARAProtara Therapeutics Inc
09/07/20218:00AMGlobeNewswire Inc.Protara Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:TARAProtara Therapeutics Inc
08/05/20214:33PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
08/05/20218:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
08/05/20218:00AMGlobeNewswire Inc.Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
07/07/20218:00AMGlobeNewswire Inc.Protara Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceNASDAQ:TARAProtara Therapeutics Inc
06/14/20215:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TARAProtara Therapeutics Inc
06/10/20218:00AMGlobeNewswire Inc.Protara Therapeutics Announces Appointment of Jane Huang, M.D. to Board of DirectorsNASDAQ:TARAProtara Therapeutics Inc
05/13/20218:00AMGlobeNewswire Inc.Protara Therapeutics to Participate in Upcoming Virtual Investor ConferencesNASDAQ:TARAProtara Therapeutics Inc
05/06/20217:14AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TARAProtara Therapeutics Inc
04/27/20214:12PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TARAProtara Therapeutics Inc
04/23/20217:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
04/23/20217:00AMGlobeNewswire Inc.Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic MalformationsNASDAQ:TARAProtara Therapeutics Inc
04/19/20214:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TARAProtara Therapeutics Inc
04/19/20214:09PMGlobeNewswire Inc.Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TARAProtara Therapeutics Inc
04/19/20218:00AMGlobeNewswire Inc.Protara Therapeutics Announces Appointment of MartĂ­n Sebastian Olivo, M.D. as Chief Medical OfficerNASDAQ:TARAProtara Therapeutics Inc
03/24/202112:23PMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:TARAProtara Therapeutics Inc
03/24/202112:21PMEdgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:TARAProtara Therapeutics Inc
03/11/20217:36AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TARAProtara Therapeutics Inc
03/11/20217:30AMGlobeNewswire Inc.Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business OverviewNASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA

Your Recent History

Delayed Upgrade Clock